1. Home
  2. HAFC vs CMPX Comparison

HAFC vs CMPX Comparison

Compare HAFC & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanmi Financial Corporation

HAFC

Hanmi Financial Corporation

HOLD

Current Price

$29.60

Market Cap

821.2M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.84

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAFC
CMPX
Founded
1982
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.2M
927.5M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
HAFC
CMPX
Price
$29.60
$1.84
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$32.17
$14.57
AVG Volume (30 Days)
228.5K
12.2M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
3.75%
N/A
EPS Growth
22.44
N/A
EPS
0.75
N/A
Revenue
$270,165,000.00
N/A
Revenue This Year
$18.65
N/A
Revenue Next Year
$7.28
$934.41
P/E Ratio
$38.71
N/A
Revenue Growth
15.28
N/A
52 Week Low
$21.84
$1.61
52 Week High
$31.33
$6.88

Technical Indicators

Market Signals
Indicator
HAFC
CMPX
Relative Strength Index (RSI) 54.51 26.23
Support Level $29.20 $1.61
Resistance Level $30.47 $3.54
Average True Range (ATR) 0.66 0.15
MACD -0.21 0.06
Stochastic Oscillator 31.58 46.05

Price Performance

Historical Comparison
HAFC
CMPX

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: